Scholars Central

PerspectivePublished 30 Jan 2023

Mother to Child Transmission Toxicity and Pharmacotherapy: HIV in Pregnancy

Authors: Sneha Srivastava

Department of Biotechnology, University of Awadh, India

Journal of Pregnancy and Child Health

Volume 10 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In 2018, an estimated 1.3 million pregnant women have HIV. All HIV-positive pregnant women, regardless of clinical stage, should take a combination of antiretroviral medications to reduce maternal viral load and avoid vertical foetal infection since HIV infection is linked to worse pregnancy outcomes. Antiretroviral therapy during pregnancy unquestionably reduced mother-to-child HIV transmission, but there are still a few unknowns. For instance, pharmacokinetic parameters alter during pregnancy, yet there is a paucity of pertinent information from clinical research. Similar to this, nothing is known about the long-term negative consequences of antiretroviral exposure on foetuses. Here, we go through the most recent research on HIV's effects on the placenta and growing baby, suggested antiviral dosages, and pharmacokinetic factors with a focus on placental transport.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pregnancy and Child Health.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pregnancy and Child Health
  • SubjectPaediatrics & Neonatology
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Sneha Srivastava”